Patients exhibiting elevated levels of eosinophils, activated natural killer (NK) cells, or naïve CD4+ T cells experienced significantly poorer overall survival (OS), and patients with high tumor mutational burden (TMB) had worse prognosis. Here, CD4 is linked to neoplasm.